Literature DB >> 26762419

In vitro and ex vivo corneal penetration and absorption models.

Priyanka Agarwal1, Ilva D Rupenthal2.   

Abstract

Topical drug administration is the preferred route of drug delivery to the eye despite the poor bioavailability. To develop more efficient drug carriers, reliable in vitro or ex vivo models are required in the early stages of formulation development, with such methods being faster, cheaper, and more ethical alternatives to in vivo studies. In vitro cell culture models are increasingly being used for transcorneal penetration studies, with primary cell cultures and immortalized cell lines now giving way to the development of organotypic corneal constructs for studying ocular drug bioavailability. Artificially cultured human corneal equivalents are still in the early stages of development, but present tremendous potential for corneal penetration studies. Ex vivo models using excised animal tissue are also being used to study corneal penetration with promising results, although significant inter-species variations need to be considered. This review discusses the in vitro and ex vivo models currently being used to study corneal penetration and evaluates their advantages and limitations with a focus on diffusion cell assemblies. In addition to the tissue used, the diffusion cell set-up can significantly influence the penetration profile and should be cautiously adjusted to simulate clinical conditions.

Entities:  

Keywords:  Corneal penetration; Diffusion cells; Ex vivo models; In vitro models; Ocular drug delivery

Mesh:

Year:  2016        PMID: 26762419     DOI: 10.1007/s13346-015-0275-6

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  105 in total

Review 1.  Biopharmaceutical considerations in topical ocular drug delivery.

Authors:  N M Davies
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-07       Impact factor: 2.557

Review 2.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

Authors:  M R Prausnitz; J S Noonan
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

3.  Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.

Authors:  Manjusha Malhotra; D K Majumdar
Journal:  Indian J Exp Biol       Date:  2002-05       Impact factor: 0.818

4.  Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.

Authors:  Chunjie Wu; Hongyi Qi; Wenwen Chen; Chunyan Huang; Cheng Su; Wenmin Li; Shixiang Hou
Journal:  Yakugaku Zasshi       Date:  2007-01       Impact factor: 0.302

5.  PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.

Authors:  E Vega; F Gamisans; M L García; A Chauvet; F Lacoulonche; M A Egea
Journal:  J Pharm Sci       Date:  2008-12       Impact factor: 3.534

6.  A novel approach to formulation factor of aceclofenac eye drops efficiency evaluation based on physicochemical characteristics of in vitro and in vivo permeation.

Authors:  Vivek Dave; Sarvesh Paliwal
Journal:  Saudi Pharm J       Date:  2013-03-30       Impact factor: 4.330

7.  Culture model of human corneal epithelium for prediction of ocular drug absorption.

Authors:  E Toropainen; V P Ranta; A Talvitie; P Suhonen; A Urtti
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-11       Impact factor: 4.799

8.  Rheological evaluation of Gelrite in situ gels for ophthalmic use.

Authors:  J Carlfors; K Edsman; R Petersson; K Jörnving
Journal:  Eur J Pharm Sci       Date:  1998-04       Impact factor: 4.384

9.  Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line.

Authors:  P Saarinen-Savolainen; T Järvinen; K Araki-Sasaki; H Watanabe; A Urtti
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

10.  Human corneal equivalent as cell culture model for in vitro drug permeation studies.

Authors:  S Reichl; J Bednarz; C C Müller-Goymann
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

View more
  13 in total

1.  Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera.

Authors:  Ana Paula Resende; Beatriz Silva; Berta São Braz; Telmo Nunes; Lídia Gonçalves; Esmeralda Delgado
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

Review 2.  In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.

Authors:  Yulia Kaluzhny; Mitchell Klausner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-05       Impact factor: 2.416

Review 3.  Nanoparticles for drug delivery to the anterior segment of the eye.

Authors:  Dileep R Janagam; Linfeng Wu; Tao L Lowe
Journal:  Adv Drug Deliv Rev       Date:  2017-04-06       Impact factor: 15.470

4.  The Therapeutic Benefits of Nanoencapsulation in Drug Delivery to the Anterior Segment of the Eye: A Systematic Review.

Authors:  Madhavi Bhandari; Sanko Nguyen; Mazyar Yazdani; Tor Paaske Utheim; Ellen Hagesaether
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

5.  Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications.

Authors:  Ahmed Adel Ali Youssef; Narendar Dudhipala; Soumyajit Majumdar
Journal:  Int J Nanomedicine       Date:  2022-05-18

6.  Design of Topical Moxifloxacin Mucoadhesive Nanoemulsion for the Management of Ocular Bacterial Infections.

Authors:  Ahmed Adel Ali Youssef; Ruchi Thakkar; Samir Senapati; Poorva H Joshi; Narendar Dudhipala; Soumyajit Majumdar
Journal:  Pharmaceutics       Date:  2022-06-12       Impact factor: 6.525

7.  Multifunctional organic-inorganic hybrid nanoparticles and nanosheets based on chitosan derivative and layered double hydroxide: cellular uptake mechanism and application for topical ocular drug delivery.

Authors:  Huibo Chi; Yan Gu; Tingting Xu; Feng Cao
Journal:  Int J Nanomedicine       Date:  2017-02-28

8.  Zinc oxide tetrapods inhibit herpes simplex virus infection of cultured corneas.

Authors:  Neil Duggal; Dinesh Jaishankar; Tejabhiram Yadavalli; Satvik Hadigal; Yogendra Kumar Mishra; Rainer Adelung; Deepak Shukla
Journal:  Mol Vis       Date:  2017-02-26       Impact factor: 2.367

Review 9.  Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis.

Authors:  Lucy Urwin; Katarzyna Okurowska; Grace Crowther; Sanhita Roy; Prashant Garg; Esther Karunakaran; Sheila MacNeil; Lynda J Partridge; Luke R Green; Peter N Monk
Journal:  Cells       Date:  2020-11-10       Impact factor: 6.600

10.  Rapid assessment of ocular drug delivery in a novel ex vivo corneal model.

Authors:  Ghazala Begum; Thomas Leigh; Ella Courtie; Richard Moakes; Gibran Butt; Zubair Ahmed; Saaeha Rauz; Ann Logan; Richard J Blanch
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.